J&J says review of illness that led to pause of coronavirus vaccine trial could take days

Johnson & Johnson said on Tuesday it would take a few days at least to hear from a safety monitoring panel about its review of the company's late-stage COVID-19 vaccine trial after announcing that the ...

J&J says review of illness that led to coronavirus vaccine trial pause could take days

Johnson & Johnson said on Tuesday it would take at least a few days for an independent safety panel to evaluate an unexplained illness of a study participant that led to a pause in the company's COVID ...

Delta Air Lines, Inc. (DAL) Q3 2025 Earnings Call Transcript

Delta Air Lines, Inc. ( NYSE: DAL) Q3 2025 Earnings Call October 9, 2025 10:00 AM EDT ...

Levi Strauss & Co. (LEVI) Q3 2025 Earnings Call Transcript

Levi Strauss & Co. ( NYSE: LEVI) Q3 2025 Earnings Call October 9, 2025 5:00 PM EDT ...
The Lancet

Parkinson's disease: emerging opportunities through global collaboration

Precision medicine holds enormous promise in enhancing treatment efficacy and advancing therapeutic development, leading to more equitable care. However, to realise this promise in all individuals ...